The event is expected to see more than 1,000 delegates gather in Melbourne from over 50 countries, with the occasion anticipated to generate $5.9 million for the economy.
The congress sees researchers, biologists, psychiatrists, neurologists, pharmacologists and psychologists meet for an exchange of knowledge from around the world.
Melbourne Convention Bureau (MCB) won the bid for the city, with support from the Victorian Government and Tourism Australia’s Business Events Bid Fund. Melbourne has hosted the event once before, in 1996.
Tourism Australia’s managing director Phillipa Harrison said the return of the event was proof of Australia’s enduring appeal for business events.
“Hosting the CINP World Congress in Neuropsychopharmacology in Melbourne for the second time demonstrates that Australia continues to attract important international association meetings which will deliver significant benefits to the visitor economy.”
Melbourne boasts strong medical technology and pharmaceutical credentials – around 23,000 professionals drive $12.7 billion in revenue across the two medical sectors each year.
As a whole Victoria has 22 pharmaceutical manufacturers, 16 major medical research institutes, 11 teaching hospitals and nine universities.
CEO of MCB, Julia Swanson, says Melbourne’s knowledge ecosystem is conducive to hosting global conferences.
“Our city’s excellent infrastructure and collaborative partnerships spanning universities, research institutions, and hospitals have cultivated an environment where the world’s most brilliant minds converge. It’s a place where inspiration thrives, innovation flourishes, and tangible transformations emerge with world-leading research and development,” said Swanson.
“This synergy has undeniably propelled the city to the forefront of global destinations for hosting conferences within the medical and healthcare sector. When you choose Melbourne to host your conference, you are harnessing the extraordinary strengths of our city’s unparalleled knowledge and innovation hub – a hub that resonates on a global scale.”
The president elect of the global association, Professor Kazutaka Ikeda, said the association was thrilled the congress would be coming to Melbourne.
“The CINP World Congress of Neuropsychopharmacology offers an outstanding international platform to hear about the latest research advances, new treatments and clinical needs and challenges and to communicate, collaborate and network with a large international audience.”